Proteomics

Dataset Information

0

DIA-SWATH analysis of the effect of cysteamine in cystinotic fibroblasts


ABSTRACT: Fibroblast cell lines form cystinotic and non-cystinotic fibroblast were incubated for 48h with increasing amounts of cysteamine, the only available treatment for cystinosis, an incurable metabolic rare disease that is characterized by accumulation of cystine crystals in the cells and accompanied by detrimental symptoms at the renal, ocular, and muscular levels. Cysteamine treatment delays the symptoms and improves the quality of life of the patients, but the patients depend on it for life. Furthermore, oral cysteamine treatment present undesirable side effects and fails in avoiding the end-stage renal failure that inevitably drives to kidney transplant. Our results will be helpful to understand, from a molecular point of view, the benefits, deficiencies, and detrimental effects of the cysteamine treatment.

INSTRUMENT(S): ZenoTOF 7600

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Jesus Mateos  

PROVIDER: MSV000095020 | MassIVE | Thu Jun 13 05:51:00 BST 2024

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-02 | BIOMD0000000908 | BioModels
2015-07-01 | E-GEOD-66079 | biostudies-arrayexpress
2016-04-28 | E-MTAB-4662 | biostudies-arrayexpress
2020-10-20 | MTBLS700 | MetaboLights
2015-07-01 | GSE66079 | GEO
2023-10-20 | GSE243694 | GEO
2022-05-15 | GSE196701 | GEO
2014-09-05 | E-GEOD-52889 | biostudies-arrayexpress
2005-01-01 | MODEL1011080004 | BioModels
2024-09-02 | BIOMD0000001015 | BioModels